Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Instinct Bio Technical Company Holdings Inc./ 6-K

SEC Filing · 6-K

Instinct Bio Technical Company Holdings Inc.

BIOTNASDAQEQUITYCurrent

SEC Filing

Filed Oct 1, 2026Accepted Oct 1, 2026, 6:01 AM EDTCIK 2072188Accession 0001104659-26-112508
View company →Permanent SEC source ↗
Share

Press release in this filing

BIOT Named Authorized Representative for IN01 Cancer Immunotherapy in Japan and China →

Company context

INC. INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) is a diversified healthcare and biotechnology company focused on developing and expanding businesses across beauty, wellness, regenerative medicine and related healthcare sectors. Through its operations and strategic partnerships, BIOT seeks to build an integrated platform connecting innovative healthcare technologies, products and services with growth opportunities across Asia and other international markets. For more information, please visit https://instinct-biot.com/

Current securities

BIOTNASDAQ · EQUITY · CurrentBIOTWNASDAQ · WARRANT · Current

Recent company filings

  1. 6-K filingSep 15, 2026
  2. 6-K filingSep 8, 2026
  3. 6-K filingAug 10, 2026
  4. 6-K filingJul 31, 2026
  5. 6-K filingJul 30, 2026

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.